Omniscan intelligence · 1 July 2026–31 July 2026

UK pharma media reputation tracker

Compare share of voice, sentiment and themes for GSK, AstraZeneca, Pfizer and 7 peers across 882 UK earned-media mentions, Jul–Jul 2026.

Reporting period
1 July 2026–31 July 2026
Articles analysed
1,018
Earned-media mentions
882
Organisations compared
10

Organisations in the benchmark

  • GSK
  • AstraZeneca
  • Pfizer
  • Eli Lilly
  • Novartis
  • MSD
  • Roche
  • Sanofi
  • Novo Nordisk
  • Moderna

What the benchmark compares

Explore share of voice, monthly visibility, coverage volume, positive and negative sentiment, net media tone and editorial themes. Compare the full cohort, then open an organisation-level deep dive for its news-cycle movement, leading themes and coverage evidence.

AstraZeneca led average share of voice at 29.4%.